Literature DB >> 26224812

Systemic Embolic Events (SEE) in Atrial Fibrillation: SEEing Embolic Risk More Clearly.

Neal A Chatterjee1, Steven A Lubitz2.   

Abstract

Entities:  

Keywords:  Editorials; arrhythmias, cardiac; atrial fibrillation; atrial flutter; embolism

Mesh：

Year:  2015        PMID： 26224812      PMCID： PMC4558335          DOI： 10.1161/CIRCULATIONAHA.115.018172

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  20 in total

1.  Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.

Authors:  Leif Friberg; Mårten Rosenqvist; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2012-01-13       Impact factor: 29.983

2.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.

Authors:  S Connolly; J Pogue; R Hart; M Pfeffer; S Hohnloser; S Chrolavicius; M Pfeffer; S Hohnloser; S Yusuf
Journal:  Lancet       Date:  2006-06-10       Impact factor: 79.321

Review 3.  Thromboembolism in atrial fibrillation.

Authors:  Jan Menke; Lars Lüthje; Andreas Kastrup; Jörg Larsen
Journal:  Am J Cardiol       Date:  2010-02-15       Impact factor: 2.778

4.  Apixaban in patients with atrial fibrillation.

Authors:  Stuart J Connolly; John Eikelboom; Campbell Joyner; Hans-Christoph Diener; Robert Hart; Sergey Golitsyn; Greg Flaker; Alvaro Avezum; Stefan H Hohnloser; Rafael Diaz; Mario Talajic; Jun Zhu; Prem Pais; Andrzej Budaj; Alexander Parkhomenko; Petr Jansky; Patrick Commerford; Ru San Tan; Kui-Hian Sim; Basil S Lewis; Walter Van Mieghem; Gregory Y H Lip; Jae Hyung Kim; Fernando Lanas-Zanetti; Antonio Gonzalez-Hermosillo; Antonio L Dans; Muhammad Munawar; Martin O'Donnell; John Lawrence; Gayle Lewis; Rizwan Afzal; Salim Yusuf
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

Review 5.  Thromboembolism associated with atrial fibrillation as a cause of limb and organ ischemia.

Authors:  Marta Wasilewska; Izabela Gosk-Bierska
Journal:  Adv Clin Exp Med       Date:  2013 Nov-Dec       Impact factor: 1.727

6.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

7.  Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation.

Authors:  Robert D McBane; David O Hodge; Waldemar E Wysokinski
Journal:  Thromb Haemost       Date:  2008-05       Impact factor: 5.249

8.  Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors:  Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

9.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Janice Pogue; Robert G Hart; Stefan H Hohnloser; Marc Pfeffer; Susan Chrolavicius; Salim Yusuf
Journal:  N Engl J Med       Date:  2009-03-31       Impact factor: 91.245

10.  Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.

Authors:  Alvaro Alonso; Bouwe P Krijthe; Thor Aspelund; Katherine A Stepas; Michael J Pencina; Carlee B Moser; Moritz F Sinner; Nona Sotoodehnia; João D Fontes; A Cecile J W Janssens; Richard A Kronmal; Jared W Magnani; Jacqueline C Witteman; Alanna M Chamberlain; Steven A Lubitz; Renate B Schnabel; Sunil K Agarwal; David D McManus; Patrick T Ellinor; Martin G Larson; Gregory L Burke; Lenore J Launer; Albert Hofman; Daniel Levy; John S Gottdiener; Stefan Kääb; David Couper; Tamara B Harris; Elsayed Z Soliman; Bruno H C Stricker; Vilmundur Gudnason; Susan R Heckbert; Emelia J Benjamin
Journal:  J Am Heart Assoc       Date:  2013-03-18       Impact factor: 5.501
View more
  2 in total

Review 1.  Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).

Authors:  Ryan Orgel; Daniel Wojdyla; David Huberman; Jonathan L Halperin; Günter Breithardt; Daniel E Singer; Keith A A Fox; Graeme J Hankey; Kenneth W Mahaffey; W Schuyler Jones; Manesh R Patel
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-05

2.  Anaplastic thyroid tumor as an embolic source of metastasis.

Authors:  Paloma González Rodríguez; Sara Mercedes Morales Gisbert; Jose Ignacio Chiriboga Granja; Maria Cano Medina; Francisco Julián Gómez Palonés
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.